Article
Screening of FDA-approved small molecules to discover inhibitors of the <i>Pseudomonas aeruginosa</i> quorum-sensing enzyme, PqsE
2025-07-25
Abstract excerpt
Pseudomonas aeruginosa is a notorious pathogen that is a leading cause of hospital-acquired infections. Due to its heightened resistance to a broad range of antibiotics, there is great need for new antimicrobial agents that are effective in treating P. aeruginosa infections. One attractive option for exploring new antibiotic targets is the quorum sensing (QS) pathway, as it governs many of the pathogenic behavior...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 067eac86-d34e-5b8d-9576-8efd78785230
- DOI
- 10.1101/2025.07.25.666791
